Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZAI LAB

29.650
+1.1003.85%
Volume:12.08M
Turnover:350.12M
Market Cap:32.70B
PE:-14.54
High:29.700
Open:28.550
Low:27.700
Close:28.550
Loading ...

HK Movers|Pharma Shares Rallied. CSPC Pharma Up 9%; 3SBio Up 4%; Yihai Up 3%; Genscript Bio And JXR Up 2%.

Tiger Newspress
·
Yesterday

Zai Lab Ltd. Announces New Compensation Plan with Grant of Share Options and Restricted Share Units under 2024 Equity Incentive Plan

Reuters
·
05 Jun

HK Movers|HK Pharma Shares Kept Rally. Zai Lab Up 7%; Hutchmed Up 6%; Immunotech Up 5%

Tiger Newspress
·
05 Jun

Zai Lab Ltd. CFO Yajing Chen Reports Disposal of Common Shares

Reuters
·
05 Jun

Stock Track | ZAI LAB Soars 6.63% Amid Hong Kong Pharmaceutical Sector Rally

Stock Track
·
04 Jun

Stock Track | ZAI LAB Soars 6.63% as Hong Kong Pharmaceutical Sector Rallies

Stock Track
·
04 Jun

HK Movers|Pharma Shares Jumped. Innovent Bio Up 15%; Zai Lab Up 5%; Junshi Bio And CSPC Pharma Up 4%

Tiger Newspress
·
04 Jun

HK Movers|HK's Pharma Shares Jumped. Medlive Up 8%; Sihuan Pharm And Junshi Bio Up 7%; Pharmaron And Fosun Pharma Up 5%

Tiger Newspress
·
03 Jun

BRIEF-Zai Lab Presents Positive Phase 1 Data For Zl-1310, A Dll3-Targeted Adc

Reuters
·
02 Jun

Zai Lab Ltd. Announces New Clinical Trial Plans for ZL-1310 in Extensive-Stage Small Cell Lung Cancer Following Promising Phase 1 Results

Reuters
·
02 Jun

Zai Lab Presents Positive Phase 1 Data for Zl-1310, a Dll3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients With Extensive-Stage Small Cell Lung Cancer at 2025 Asco Annual Meeting

THOMSON REUTERS
·
02 Jun

Zai Lab and Novocure Announce Results From the Phase 3 Panova-3 Trial of Tumor Treating Fields (Ttfields) Therapy for Pancreatic Cancer to Be Presented at 2025 Asco Annual Meeting

THOMSON REUTERS
·
01 Jun

Zai Lab Ltd. to Participate in Jefferies Global Healthcare Conference Fireside Chat

Reuters
·
30 May

HK Movers | HK's Biotech Shares Soar. Asymchem up 15%; Laekna up 13%; Ascletis, CanSinoBIO up 9%

Tiger Newspress
·
21 May

HK Movers | HK's Biotech Shares Soar. Cstone Pharma Soars 20%; RemeGen up 10%; Ascletis up 6%

Tiger Newspress
·
20 May

BRIEF-Zai Lab Receives U.S. FDA Fast Track Designation For Zl-1310, A Dll3-Targeted Antibody-Drug Conjugate, For Treatment Of Extensive-Stage Small Cell Lung Cancer

Reuters
·
19 May

Zai Lab Ltd. Secures FDA Fast Track Designation for ZL-1310 in Treating Extensive-Stage Small Cell Lung Cancer

Reuters
·
19 May

Zai Lab Ltd - to Initiate Pivotal Study for Zl-1310 in 2025

THOMSON REUTERS
·
19 May

Zai Lab Receives U.S. FDA Fast Track Designation for Zl-1310, a Dll3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer

THOMSON REUTERS
·
19 May

Zai Lab Ltd. Announces New Restricted Share Units Grant Under 2024 Equity Incentive Plan

Reuters
·
14 May